CHI Memorial
Approved Hospital Formulary
Epic Issue Reporting
Pharmacy Google Site
AUC CALCULATOR FEEDBACK
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warnings
FDA Safety Alerts
Look Alike/Sound Alike
Restricted Drugs
Therapeutic Substitutions
Non-Formulary, Specialty
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
Boards
CHI Memorial
Approved Hospital Formulary
Epic Issue Reporting
Pharmacy Google Site
AUC CALCULATOR FEEDBACK
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warnings
FDA Safety Alerts
Look Alike/Sound Alike
Restricted Drugs
Therapeutic Substitutions
Non-Formulary, Specialty
Webpage Links
Restricted Drugs
Please review each of these drugs carefully.
abatacept
See Therapeutic Restrictions to Outpatient Locations
adalimumab
See Therapeutic Restrictions to Outpatient Locations
ado-trastuzumab
See Therapeutic Restrictions to Outpatient Locations
albiglutide
Non-formulary - patient may use own med
alendronate
See bisphosphonate restrictions
alvimopan
See Restrictions
aminolevulinic acid
See restrictions
amphotericin B
See restrictions.
amphotericin B lipid complex
See restrictions.
atezolizumab
Restricted to oupatient use only
avelumab
See Therapeutic Restrictions to Outpatient Locations
belimumab
See Therapeutic Restrictions to Outpatient Locations
benralizumab
See Therapeutic Restrictions to Outpatient Locations
bevacizumab
See Therapeutic Restrictions to Outpatient Locations
bevacizumab-awwb
See Therapeutic Restrictions to Outpatient Locations
bevacizumab-bvzr
See Therapeutic Restrictions to Outpatient Locations
bezlotoxumab
See restrictions
blinatumomab
See Therapeutic Restrictions to Outpatient Locations
brentuximab vedotin
See Therapeutic Restrictions to Outpatient Locations
brivaracetam
New starts restricted to neurology
bupivacaine liposomal
Non-formulary per P&T April 2016
C1 Inhibitor, Human
For Cinryze, see Therapeutic Restrictions to Outpatient Locations
caplacizumab-yhdp
Restricted Use Guidelines
carfilzomib
See Therapeutic Restrictions to Outpatient Locations
ceftaroline
See restrictions
ceftazidime
May be ordered by ID or approved by Antimicrobial Stewardship Team.
ceftazidime-avibactam
See Restriction Criteria
ceftolozane-tazobactam
See restrictions
cemiplimab-rwlc
See Therapeutic Restrictions to Outpatient Locations
certolizumab
Designated Non-formulary by P&T
cetuximab
See Therapeutic Restrictions to Outpatient Locations
ciprofloxacin
May be ordered by ID or for documented Pseudomonas ONLY.
cisatracurium
See Miscellaneous Restrictions
cobicistat
Restricted
collagenase topical
See Restriction Criteria
dalfopristin-quinupristin
See restrictions
DAPTOmycin
See restrictions
daratumumab
See Therapeutic Restrictions to Outpatient Locations
darbepoetin alfa
See Therapeutic Restrictions to Outpatient Locations
denosumab
See Policy (Only for Outpatients with CrCl < 35 ml/min)
digoxin immune FAB
Restricted Use Guidelines
dronedarone
Restricted Use Guidelines
droperidol
See restrictions
durvalumab
See Therapeutic Restrictions to Outpatient Locations
eculizumab
See Therapeutic Restrictions to Outpatient Locations
empagliflozin
See restrictions
epoetin alfa
See Therapeutic Restrictions to Outpatient Locations
eptinezumab
Restricted to outpatient use only
eriBULin
See Therapeutic Restrictions to Outpatient Locations
ertapenem
Restricted Use Guidelines
ethacrynic acid
See Restrictions
etidronate
See bisphosphonate restrictions]
exenatide
Not on formulary - patient may use own med
ferumoxytol
Only approved for outpatient use.
fexofenadine
See Therapeutic Restrictions to Outpatient Locations
fidaxomicin
See restrictions
fulvestrant
See Therapeutic Restrictions to Outpatient Locations
gemtuzumab
See Therapeutic Restrictions to Outpatient Locations
golimumab
See Therapeutic Restrictions to Outpatient Locations
goserelin
See Therapeutic Restrictions to Outpatient Locations
granisetron
Restricted Use Guidelines
ibandronate
See bisphosphonate restrictions
ibuprofen IV
See Analgesic Restrictions
inFLIXimab
See Restrictions
ipilimumab
Approved on a case by case basis for outpatient use only.
isavuconazonium
Restricted to ID
ixabepilone
See Therapeutic Restrictions to Outpatient Locations
leuprolide
See Therapeutic Restrictions to Outpatient Locations
levalbuterol
On formulary with restrictions
levothyroxine
See restricted use criteria for IV levothyroxine
linaclotide
Restricted to continuation of home meds only
linezolid
See restrictions
liraglutide
Not on formulary - patient may use own med
lubiprostone
Restricted to continuation of home meds only
lurasidone
Use is restricted to continuation of home therapy
lurbinectedin
See restrictions
meperidine
See analgesic restrictions
meropenem
See restrictions
methylnaltrexone
See Restrictions
micafungin
May only be ordered by ID or Intensivists.
moxifloxacin
May be ordered by ID
naloxegol
See restrictions
natalizumab
See Therapeutic Restrictions to Outpatient Locations
necitumumab
See Therapeutic Restrictions to Outpatient Locations
nitazoxanide
See Restrictions
nitrofurantoin
Nitrofurantoin macrocrystals (Macrodantin) restricted to patients requiring medication administration via feeding tube.
nivolumab
See Therapeutic Restrictions to Outpatient Locations
obinutuzumab
See Therapeutic Restrictions to Outpatient Locations
ocrelizumab
See Therapeutic Restrictions to Outpatient Locations
octreotide
For Sandostatin LAR, see Therapeutic Restrictions to Outpatient Locations
ofatumumab
See Therapeutic Restrictions to Outpatient Locations
omalizumab
See Therapeutic Restrictions to Outpatient Locations
oritavancin
See anti-infective restrictions
PACLitaxel protein-bound
See Therapeutic Restrictions to Outpatient Locations
paliperidone XR
Not on formulary - patient may use own med. Call MD and recommend Risperidone for new starts.
palonosetron
See Restrictions
panitumumab
See Therapeutic Restrictions to Outpatient Locations
pegfilgrastim
Restricted to outpatient use
pembrolizumab
See Therapeutic Restrictions to Outpatient Locations
pentamidine
See restriction criteria for IV formulation
peramivir
See Anti-infective Restrictions
pertuzumab
See Therapeutic Restrictions to Outpatient Locations
pneumococcal 23-valent vaccine
See restrictions
polidocanol
See restriction criteria
posaconazole
See Restriction Criteria
pramlintide
Not on formulary. Patient may use home supply.
prasugrel
Restricted Use Guidelines
qual
Restricted Use
ramucirumab
See Therapeutic Restrictions to Outpatient Locations
remifentanil
See restrictions
risedronate
See bisphosphonate restrictions
riTUXimab
See Therapeutic Restrictions to Outpatient Locations
rituximab-abbs
See Therapeutic Restrictions to Outpatient Locations
rituximab-pvvr
See Therapeutic Restrictions to Outpatient Locations
roflumilast
See Restrictions
sacubitril-valsartan
See restrictions
selegiline
Restricted Use Guidelines
simvastatin
Use of 80-mg dose of simvastatin should be restricted to patients who have been taking that dose chronically (eg, for 12 months or more) without evidence of muscle toxicity.
sugammadex
See restrictions
temsirolimus
See Therapeutic Restrictions to Outpatient Locations
tigecycline
See restrictions
Tocilizumab
See Therapeutic Restrictions to Outpatient Locations
tolvaptan
Restricted Use Guidelines
trastuzumab
See Therapeutic Restrictions to Outpatient Locations
trastuzumab-anns
See Therapeutic Restrictions to Outpatient Locations
varicella-zoster vaccine live
Restricted to outpatient
vedolizumab
Outpatient use only
venetoclax
See restriction criteria
voriconazole
See restrictions
zaleplon
May use only for Neuro pts since shorter acting (MD must fill out Non-Formulary Request Form!)
zoledronic acid
See Therapeutic Restrictions to Outpatient Locations